|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500096230 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-20 17:29:28 |
|
注册时间: Date of Registration: |
2025-01-20 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于ERAS理念在多学科协作下结直肠癌患者围手术期的应用研究 |
|
Public title: |
The impact of ERAS and multidisciplinary teams on preoperative management in colorectal cancer |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于ERAS理念在多学科协作下结直肠癌患者围手术期的应用研究 |
|
Scientific title: |
The impact of ERAS and multidisciplinary teams on preoperative management in colorectal cancer |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张倩倩 |
研究负责人: |
张倩倩 |
|
Applicant: |
Qianqian Zhang |
Study leader: |
Qianqian Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 139 5739 5339 |
研究负责人电话:
Study leader's |
+86 139 5739 5339 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
echo_us1879@163.com |
研究负责人电子邮件: Study leader's E-mail: |
echo_us1879@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国浙江省海盐县武原街道建丰路699号 |
研究负责人通讯地址: |
中国浙江省海盐县武原街道建丰路699号 |
|
Applicant address: |
No. 699, Jianfeng Road, Wuyuan Sub-district, Haiyan , Zhejiang Province, China |
Study leader's address: |
No. 699, Jianfeng Road, Wuyuan Sub-district, Haiyan , Zhejiang Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
314300 |
研究负责人邮政编码: Study leader's postcode: |
314300 |
|
申请人所在单位: |
海盐县人民医院 |
||
|
Applicant's institution: |
Haiyan People's Hospital Zhejiang,China |
||
|
研究负责人所在单位: |
海盐县人民医院 |
||
|
Affiliation of the Leader: |
Haiyan People's Hospital Zhejiang,China |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2023年度)伦审研 第(41)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
海盐县人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Haiyan People's Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-20 00:00:00 | ||
|
伦理委员会联系人: |
邬梅珍 |
||
|
Contact Name of the ethic committee: |
Meizhen Wu |
||
|
伦理委员会联系地址: |
中国浙江省海盐县武原街道建丰路699号 |
||
|
Contact Address of the ethic committee: |
No. 699, Jianfeng Road, Wuyuan Sub-district, Haiyan , Zhejiang Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 573 8622 9442 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
hyryyjk@163.com |
|
研究实施负责(组长)单位: |
海盐县人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Haiyan People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国浙江省海盐县武原街道建丰路699号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 699, Jianfeng Road, Wuyuan Sub-district, Haiyan , Zhejiang Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国浙江省海盐县卫生健康局 (2023; WS016) |
||||||||||||||||||||||
|
Source(s) of funding: |
Health Research Project of Haiyan, Zhejiang Province, China (2023; WS016). |
||||||||||||||||||||||
|
研究疾病: |
结直肠恶性肿瘤 |
||||||||||||||||||||||
|
Target disease: |
Colorectal Cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究假设,与传统护理相比,将加速康复术后 (ERAS) 方案与多学科合作相结合将改善结直肠癌患者的疼痛管理和围手术期整体结局。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study hypothesized that integrating the Enhanced Recovery After Surgery (ERAS) protocol with multidisciplinary collaboration would improve pain management and overall perioperative outcomes for colorectal cancer patients compared to traditional care. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)经病理诊断确诊为结直肠癌; (2)年龄30-80周岁; (3)意识清晰且具有一定沟通能力; (4)无其他内分泌合并症; (5)心功能≥3 级; (6)知情同意,自愿参与本次研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. they had a pathological diagnosis of colorectal cancer, 2. were between the ages of 30 and 80, 3. voluntarily participated with informed consent, 4. No other endocrine-related complications,and 5. had a cardiac function classified as grade 3 or above . 6. Informed consent and voluntary participation in this research are required. |
||||||||||||||||||||||
|
排除标准: |
(1)合并其他部位恶性肿瘤者; (2)伴有其他器官严重功能障碍者; (3)精神异常,难以进行有效沟通交流者; (4)在随访过程中因患者个人因素失访的病例。 (5)妊娠、哺乳期妇女。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. they had malignant tumors in other parts of the body, 2. severe dysfunction of other organs, 3. abnormal mental status or difficulty in communicating effectively, 4. were lost to follow-up, 5. were pregnant or lactating, |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-08-01 00:00:00至 To 2024-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-03 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
门诊医生按照纳入和排除标准,收治符合条件的患者。主班护士将患者姓名导入EXCLE,选定要生成随机数的单元格,例如A1。在A1单元格输入以下公式:=RAND( )即可生成。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The outpatient doctor admits patients who meet the inclusion and exclusion criteria. The head nurse enters the patient's name into EXCLE and selects the cell where the random number will be generated, for example, A1. Enter the following formula in cell A1: =RAND() to generate a random number., |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
数据公开时间为5年,数据共享方式为电子数据采集和管理系统(Electronic Data Capture, EDC)。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The Data disclosure period is 5 years, and the data sharing method is Electronic Data Capture and Management system (EDC). |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子数据采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |